Cannabis Bioscience International Holdings (CBIH) EBITDA Margin (QoQ) (2023 - 2026)
Cannabis Bioscience International Holdings (CBIH) EBITDA Margin (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -65,230.00 |
| Nov 30, 2025 | 12,903.00 |
| Aug 31, 2025 | 7,689.00 |
| May 31, 2025 | 47,963.00 |
| Feb 28, 2025 | -78,523.00 |
| Nov 30, 2024 | -2,575.00 |
| Aug 31, 2024 | -1,550.00 |
| May 31, 2024 | 40,028.00 |
| Feb 29, 2024 | -29,109.00 |
| Nov 30, 2023 | 9,451.00 |
| Aug 31, 2023 | 34,953.00 |
| May 31, 2023 | -3,648.00 |
| Feb 28, 2023 | -33,348.00 |